PDCD1 and gastric cancer: Moreover, Treg cells also express PD-1 and thus systemic PD-1/PD-L1 blockade would lead to enhancement of Treg cell function, thereby significantly suppressing antitumor immune responses and causing a state of hyper-progressive disease in gastric cancer (93–95).